MLTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.02%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,186,120.00

MoonLake Immunotherapeutics Insider Trading History Chart

MoonLake Immunotherapeutics Share Price & Price History

^$39.53

▲ +0.015 (0.04%)

As of 04/24/2025 04:27 PM ET

Days: 30 | 90 | 365

MoonLake Immunotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2024	Simon Sturge	Director	Sell	171,000	$53.72	$9,186,120.00	171,980
2/29/2024	Da Silva Jorge Santos	CEO	Sell	4,740	$55.89	$264,918.60	2,982,814
2/27/2024	Da Silva Jorge Santos	CEO	Sell	62,810	$55.00	$3,454,550.00	3,043,619
2/27/2024	Kristian Reich	Insider	Sell	29,431	$55.00	$1,618,705.00	70,071
2/20/2024	Da Silva Jorge Santos	CEO	Sell	20,000	$57.44	$1,148,800.00	3,107,554
2/20/2024	Kristian Reich	Insider	Sell	10,000	$57.43	$574,300.00	100,071
2/16/2024	Kristian Reich	Insider	Sell	10,000	$60.15	$601,500.00	110,071
2/15/2024	Da Silva Jorge Santos	CEO	Sell	20,000	$60.18	$1,203,600.00	3,147,554
2/14/2024	Kristian Reich	Insider	Sell	10,000	$62.43	$624,300.00	130,071
12/19/2023	Matthias Bodenstedt	CFO	Sell	94,736	$59.22	$5,610,265.92	526,167
10/4/2023	Bihua Chen	Major Shareholder	Buy	67,814	$57.32	$3,887,098.48	8,435,312
10/2/2023	Bihua Chen	Major Shareholder	Buy	74,911	$57.37	$4,297,644.07	8,217,011
6/30/2023	Bihua Chen	Major Shareholder	Buy	800,000	$50.00	$40,000,000.00	4,927,100
6/26/2023	Bihua Chen	Major Shareholder	Buy	450,000	$45.63	$20,533,500.00	4,127,100
3/20/2023	Bihua Chen	Major Shareholder	Buy	588,589	$19.71	$11,601,089.19	3,438,589

SEC Filings (Institutional Ownership Changes) for MoonLake Immunotherapeutics (NASDAQ:MLTX)

93.85% of MoonLake Immunotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MoonLake Immunotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/14/2025	Harbor Capital Advisors Inc.	102,020	$3.99M	0.2%	+28.1%	0.159%
3/24/2025	Wellington Management Group LLP	99,098	$5.37M	0.0%	-48.4%	0.155%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	20,141	$1.09M	0.0%	N/A	0.032%
2/27/2025	Jefferies Financial Group Inc.	6,250	$0.34M	0.0%	N/A	0.010%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	42,236	$2.29M	0.0%	+17.9%	0.066%
2/17/2025	Woodline Partners LP	293,535	$15.90M	0.1%	+26.3%	0.459%
2/17/2025	Wexford Capital LP	24,000	$1.30M	0.2%	+71.4%	0.038%
2/17/2025	Point72 Asset Management L.P.	98,719	$5.35M	0.0%	N/A	0.154%
2/17/2025	Polar Capital Holdings Plc	1,100,000	$59.57M	0.3%	+120.0%	1.721%
2/17/2025	MPM Bioimpact LLC	315,230	$17.07M	2.4%	-9.7%	0.493%
2/17/2025	Paradigm Biocapital Advisors LP	1,772,211	$95.97M	3.3%	+90.3%	2.773%
2/17/2025	Parkman Healthcare Partners LLC	54,294	$2.94M	0.4%	-47.2%	0.085%
2/17/2025	Nuveen Asset Management LLC	595,581	$32.25M	0.0%	+2.5%	0.932%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	20,740	$1.12M	0.1%	+29.6%	0.032%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	15,456	$0.84M	0.0%	+13.7%	0.024%
2/17/2025	Integral Health Asset Management LLC	200,000	$10.83M	0.9%	-9.1%	0.313%
2/17/2025	Jefferies Financial Group Inc.	6,250	$0.34M	0.0%	N/A	0.010%
2/17/2025	Granahan Investment Management LLC	136,438	$7.39M	0.3%	-21.0%	0.214%
2/17/2025	Ensign Peak Advisors Inc	9,139	$0.50M	0.0%	-78.4%	0.014%
2/17/2025	Fred Alger Management LLC	673,773	$36.49M	0.2%	+1.1%	1.054%
2/17/2025	Deutsche Bank AG	903	$49K	0.0%	+59.8%	0.001%
2/17/2025	Caption Management LLC	12,371	$0.67M	0.0%	N/A	0.019%
2/17/2025	BVF Inc. IL	19,751,284	$1.07B	36.3%	-9.2%	30.910%
2/17/2025	Balyasny Asset Management L.P.	206,568	$11.19M	0.0%	-42.7%	0.323%
2/17/2025	Bank of America Corp DE	45,540	$2.47M	0.0%	-62.7%	0.071%
2/17/2025	BNP Paribas Financial Markets	7,633	$0.41M	0.0%	N/A	0.012%
2/17/2025	Ameriprise Financial Inc.	204,373	$11.07M	0.0%	+28.3%	0.320%
2/14/2025	Schonfeld Strategic Advisors LLC	3,911	$0.21M	0.0%	-95.5%	0.006%
2/14/2025	Northern Trust Corp	14,261	$0.77M	0.0%	+161.7%	0.022%
2/14/2025	The Manufacturers Life Insurance Company	142,702	$7.73M	0.0%	+20.8%	0.223%
2/14/2025	Decheng Capital LLC	171,600	$9.29M	2.0%	+3.0%	0.269%
2/14/2025	Birchview Capital LP	4,000	$0.22M	0.2%	N/A	0.006%
2/14/2025	Virtus ETF Advisers LLC	1,322	$72K	0.0%	-38.9%	0.002%
2/14/2025	Voya Investment Management LLC	448,860	$24.31M	0.0%	+9.7%	0.702%
2/14/2025	Adage Capital Partners GP L.L.C.	155,000	$8.39M	0.0%	-69.3%	0.243%
2/14/2025	Hood River Capital Management LLC	649,590	$35.18M	0.5%	+0.5%	1.017%
2/14/2025	Price T Rowe Associates Inc. MD	3,343,643	$181.06M	0.0%	+12.2%	5.233%
2/14/2025	Dimensional Fund Advisors LP	64,384	$3.49M	0.0%	N/A	0.101%
2/13/2025	Marshall Wace LLP	1,245,299	$67.43M	0.1%	+7.9%	1.949%
2/13/2025	PEAK6 LLC	5,000	$0.27M	0.0%	N/A	0.008%
2/13/2025	Mariner LLC	5,028	$0.27M	0.0%	N/A	0.008%
2/13/2025	Barclays PLC	4,646	$0.25M	0.0%	-17.6%	0.007%
2/13/2025	Legal & General Group Plc	19,480	$1.06M	0.0%	-6.6%	0.030%
2/13/2025	ADAR1 Capital Management LLC	17,424	$0.94M	0.2%	-25.7%	0.027%
2/13/2025	FMR LLC	6,341,391	$343.39M	0.0%	+28.1%	9.924%
2/13/2025	Federated Hermes Inc.	1,280,052	$69.32M	0.2%	+13.2%	2.003%
2/13/2025	Finepoint Capital LP	447,935	$24.26M	1.5%	+15.2%	0.701%
2/13/2025	Russell Investments Group Ltd.	55,890	$3.03M	0.0%	-9.9%	0.087%
2/12/2025	Cinctive Capital Management LP	10,576	$0.57M	0.0%	N/A	0.017%
2/12/2025	Geode Capital Management LLC	58,950	$3.19M	0.0%	+0.9%	0.092%
2/12/2025	Alliancebernstein L.P.	1,022,604	$55.37M	0.0%	+2.5%	1.600%
2/12/2025	Wellington Management Group LLP	99,098	$5.37M	0.0%	-48.4%	0.155%
2/12/2025	Clearbridge Investments LLC	43,380	$2.35M	0.0%	+26.6%	0.068%
2/12/2025	DnB Asset Management AS	8,356	$0.45M	0.0%	+11.3%	0.013%
2/12/2025	Pictet Asset Management Holding SA	346,617	$18.77M	0.0%	-2.9%	0.542%
2/12/2025	BIT Capital GmbH	20,748	$1.12M	0.1%	N/A	0.032%
2/11/2025	LPL Financial LLC	8,146	$0.44M	0.0%	+19.5%	0.013%
2/11/2025	KLP Kapitalforvaltning AS	4,500	$0.24M	0.0%	N/A	0.007%
2/11/2025	Sei Investments Co.	22,025	$1.19M	0.0%	+5.8%	0.034%
2/11/2025	Teacher Retirement System of Texas	6,532	$0.35M	0.0%	+18.4%	0.010%
2/7/2025	PNC Financial Services Group Inc.	8,500	$0.46M	0.0%	+3.9%	0.013%
2/7/2025	Candriam S.C.A.	227,476	$12.32M	0.1%	-4.8%	0.356%
2/6/2025	Victory Capital Management Inc.	178,501	$9.67M	0.0%	-18.1%	0.279%
2/4/2025	Y Intercept Hong Kong Ltd	9,229	$0.50M	0.0%	-54.6%	0.014%
2/3/2025	Handelsbanken Fonder AB	11,100	$0.60M	0.0%	-14.6%	0.017%
1/31/2025	Rice Hall James & Associates LLC	111,133	$6.02M	0.3%	+47.3%	0.174%
1/30/2025	Congress Asset Management Co.	72,993	$3.95M	0.0%	+9.5%	0.114%
1/10/2025	Harbor Capital Advisors Inc.	79,648	$4.31M	0.2%	+2.8%	0.125%
12/26/2024	JPMorgan Chase & Co.	1,236	$62K	0.0%	-93.0%	0.002%
11/19/2024	Barclays PLC	5,641	$0.28M	0.0%	+1,269.2%	0.009%
11/15/2024	Barclays PLC	5,641	$0.28M	0.0%	+1,269.2%	0.009%
11/15/2024	Y Intercept Hong Kong Ltd	20,325	$1.03M	0.1%	+55.4%	0.032%
11/15/2024	Wellington Management Group LLP	192,058	$9.68M	0.0%	-48.5%	0.301%
11/15/2024	State Street Corp	87,637	$4.42M	0.0%	+96.2%	0.137%
11/15/2024	Parkman Healthcare Partners LLC	102,813	$5.18M	0.7%	+1.6%	0.161%
11/15/2024	HighVista Strategies LLC	43,541	$2.20M	0.8%	+3.1%	0.068%
11/15/2024	Holocene Advisors LP	1,585,167	$79.92M	0.3%	-2.5%	2.481%
11/15/2024	Erste Asset Management GmbH	15,000	$0.74M	0.0%	N/A	0.023%
11/14/2024	Fred Alger Management LLC	666,574	$33.61M	0.2%	+1.1%	1.043%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	35,814	$1.81M	0.0%	+96.4%	0.056%
11/13/2024	FMR LLC	4,950,224	$249.59M	0.0%	+35.8%	7.749%
11/13/2024	The Manufacturers Life Insurance Company	118,126	$5.96M	0.0%	+3.4%	0.185%
11/12/2024	Westfield Capital Management Co. LP	1,167,358	$58.86M	0.3%	+4.4%	1.827%
11/5/2024	Victory Capital Management Inc.	217,839	$10.98M	0.0%	+24.7%	0.341%
11/5/2024	GSA Capital Partners LLP	22,127	$1.12M	0.1%	+1.9%	0.035%
10/30/2024	AlphaCentric Advisors LLC	14,000	$0.71M	0.5%	N/A	0.022%
10/29/2024	Harbor Capital Advisors Inc.	77,468	$3.91M	0.2%	+100.2%	0.121%
10/28/2024	Rice Hall James & Associates LLC	75,469	$3.81M	0.2%	N/A	0.118%
10/28/2024	US Bancorp DE	869	$44K	0.0%	N/A	0.001%
10/28/2024	Congress Asset Management Co.	66,641	$3.36M	0.0%	N/A	0.104%
10/5/2024	Handelsbanken Fonder AB	13,000	$0.66M	0.0%	+26.2%	0.020%
8/16/2024	Quarry LP	3,000	$0.13M	0.0%	+172.7%	0.005%
8/15/2024	The Manufacturers Life Insurance Company	114,234	$5.02M	0.0%	+37.9%	0.179%
8/15/2024	Millennium Management LLC	216,964	$9.54M	0.0%	+596.0%	0.340%
8/14/2024	Fred Alger Management LLC	659,029	$28.98M	0.1%	-1.2%	1.032%
8/14/2024	Marshall Wace LLP	1,098,630	$48.31M	0.1%	+115.0%	1.720%
8/14/2024	Logos Global Management LP	750,000	$32.98M	2.6%	N/A	1.174%
8/14/2024	Integral Health Asset Management LLC	220,000	$9.67M	0.9%	-47.6%	0.344%
8/14/2024	Avoro Capital Advisors LLC	2,770,000	$121.80M	1.6%	+7.4%	4.336%
8/14/2024	HighVista Strategies LLC	42,249	$1.86M	0.7%	-29.3%	0.066%

Data available starting January 2016

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Today's Range

Now: $39.53

$38.60

$40.06

50 Day Range

MA: $38.81

$32.83

$43.21

52 Week Range

Now: $39.53

$31.42

$58.26

Volume

236,995 shs

Average Volume

344,311 shs

Market Capitalization

$2.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of MoonLake Immunotherapeutics?: MoonLake Immunotherapeutics' top insider shareholders include:
Bihua Chen (Major Shareholder)
Da Silva Jorge Santos (CEO)
Matthias Bodenstedt (CFO)
Simon Sturge (Director)
Kristian Reich (Insider)
Learn More about top insider investors at MoonLake Immunotherapeutics.
Who are the major institutional investors of MoonLake Immunotherapeutics?: MoonLake Immunotherapeutics' top institutional shareholders include:
Harbor Capital Advisors Inc. — 0.16%
Learn More about top institutional investors of MoonLake Immunotherapeutics stock.
Which institutional investors are buying MoonLake Immunotherapeutics stock?: In the last quarter, MLTX stock was acquired by institutional investors including:
Harbor Capital Advisors Inc.